Antifungal (Azole) — Topical/Vaginal
Pregnancy: Safe in pregnancy — topical clotrimazole pessary (not oral azoles)
Clotrimazole (Vulvovaginal Candidiasis)
Brand names: Canesten, Canesten Combi
Adult dose
Dose: Pessary: 500 mg single dose vaginally (stat), or 200 mg vaginally once nightly for 3 nights, or 100 mg once nightly for 6 nights. External cream: 1% clotrimazole BD–TDS for 1–2 weeks to vulva
Route: Vaginal pessary or intravaginal cream + topical external cream
Frequency: Single dose (500 mg) or multi-night course
Max: 500 mg single pessary or 200 mg × 3 nights
Canesten Combi: 500 mg pessary + 2% external cream combined pack (convenient). Recurrent VVC (≥4 episodes/year): induction then 150 mg fluconazole oral weekly for 6 months (or clotrimazole 500 mg pessary weekly). Clotrimazole preferred in pregnancy (oral fluconazole — see contraindications).
Paediatric dose
Route: N/A
Frequency: N/A
Max: N/A
Not applicable in obstetric/gynaecological indication
Dose adjustments
Renal
No dose adjustment required (topical/local action)
Hepatic
No dose adjustment required (topical/local action)
Clinical pearls
- VVC (thrush) first-line treatment — clotrimazole pessary or oral fluconazole 150 mg stat (equally effective)
- Oral fluconazole contraindicated in pregnancy — use clotrimazole pessary only (topical safe throughout pregnancy)
- BASHH: first-line for uncomplicated VVC is single-dose clotrimazole 500 mg pessary or fluconazole 150 mg oral
- Latex warning: all oil-based vaginal treatments (creams, pessaries) weaken latex condoms and diaphragms — counsel patients
- Recurrent VVC: rule out diabetes, immunosuppression, antibiotics as triggers before commencing suppressive therapy
Contraindications
- Latex condom or diaphragm use (clotrimazole damages latex — avoid intercourse or use non-latex contraception during treatment)
- Known hypersensitivity
Side effects
- Local vaginal irritation or burning (transient)
- Vulval erythema
- Mild abdominal cramps (rare)
Interactions
- Latex contraceptives — damages latex (use non-latex or abstain)
Monitoring
- Symptom resolution at 1 week
- Recurrence assessment
- Underlying conditions if recurrent (e.g., diabetes, HIV)
Reference: BNFc; BASHH VVC Guideline 2019; NICE CKS Thrush (Vaginal); BNF. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21